CA2647674A1 - Detecteurs d'analytes et leurs procedes d'utilisation - Google Patents

Detecteurs d'analytes et leurs procedes d'utilisation Download PDF

Info

Publication number: CA2647674A1
Authority: CA; Canada
Prior art keywords: sample chamber; sensor; electrode; sample; electrodes
Prior art date: 2006-03-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002647674A

Other languages

English (en)

Inventor

Yi Wang

Benjamin J. Feldman

Jared L. Watkin

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Abbott Diabetes Care Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-03-29

Filing date

2007-03-28

Publication date

2007-11-08

2007-03-28 Application filed by Individual filed Critical Individual

2007-11-08 Publication of CA2647674A1 publication Critical patent/CA2647674A1/fr

Status Abandoned legal-status Critical Current

Links

239000012491 analyte Substances 0.000 title claims abstract description 50
238000000034 method Methods 0.000 title claims abstract description 22
239000000758 substrate Substances 0.000 claims description 115
125000006850 spacer group Chemical group 0.000 claims description 36
239000013060 biological fluid Substances 0.000 claims description 11
238000000338 in vitro Methods 0.000 abstract 1
238000005259 measurement Methods 0.000 description 30
239000012530 fluid Substances 0.000 description 16
239000000463 material Substances 0.000 description 15
239000012992 electron transfer agent Substances 0.000 description 11
238000003556 assay Methods 0.000 description 9
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
210000004369 blood Anatomy 0.000 description 8
239000008280 blood Substances 0.000 description 8
239000008103 glucose Substances 0.000 description 8
239000010410 layer Substances 0.000 description 8
238000004458 analytical method Methods 0.000 description 6
239000012633 leachable Substances 0.000 description 6
238000000465 moulding Methods 0.000 description 6
-1 polyethylene Polymers 0.000 description 6
239000004020 conductor Substances 0.000 description 5
238000010276 construction Methods 0.000 description 5
238000012544 monitoring process Methods 0.000 description 5
230000003213 activating effect Effects 0.000 description 4
229920000642 polymer Polymers 0.000 description 4
238000012546 transfer Methods 0.000 description 4
108090000790 Enzymes Proteins 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
239000000853 adhesive Substances 0.000 description 3
230000001070 adhesive effect Effects 0.000 description 3
239000012298 atmosphere Substances 0.000 description 3
238000004891 communication Methods 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
210000003722 extracellular fluid Anatomy 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
229910021607 Silver chloride Inorganic materials 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
230000000875 corresponding effect Effects 0.000 description 2
CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
238000001514 detection method Methods 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
238000000840 electrochemical analysis Methods 0.000 description 2
238000007812 electrochemical assay Methods 0.000 description 2
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
238000011002 quantification Methods 0.000 description 2
WOCIAKWEIIZHES-UHFFFAOYSA-N ruthenium(iv) oxide Chemical compound O=[Ru]=O WOCIAKWEIIZHES-UHFFFAOYSA-N 0.000 description 2
HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
150000003623 transition metal compounds Chemical group 0.000 description 2
230000001960 triggered effect Effects 0.000 description 2
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
239000004382 Amylase Substances 0.000 description 1
102000013142 Amylases Human genes 0.000 description 1
108010065511 Amylases Proteins 0.000 description 1
102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
102000004420 Creatine Kinase Human genes 0.000 description 1
108010042126 Creatine kinase Proteins 0.000 description 1
WDJUZGPOPHTGOT-OAXVISGBSA-N Digitoxin Natural products O([C@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@H](C6=CC(=O)OC6)CC5)CC4)CC3)CC2)C[C@H]1O)[C@H]1O[C@@H](C)[C@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)C2)[C@@H](O)C1 WDJUZGPOPHTGOT-OAXVISGBSA-N 0.000 description 1
LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
239000004593 Epoxy Substances 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
102100038358 Prostate-specific antigen Human genes 0.000 description 1
102100027378 Prothrombin Human genes 0.000 description 1
108010094028 Prothrombin Proteins 0.000 description 1
KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
102000011923 Thyrotropin Human genes 0.000 description 1
108010061174 Thyrotropin Proteins 0.000 description 1
108090001027 Troponin Proteins 0.000 description 1
108010059993 Vancomycin Proteins 0.000 description 1
OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
229960004373 acetylcholine Drugs 0.000 description 1
239000002313 adhesive film Substances 0.000 description 1
239000012790 adhesive layer Substances 0.000 description 1
239000002390 adhesive tape Substances 0.000 description 1
238000004082 amperometric method Methods 0.000 description 1
235000019418 amylase Nutrition 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
229940107161 cholesterol Drugs 0.000 description 1
229940015047 chorionic gonadotropin Drugs 0.000 description 1
150000001869 cobalt compounds Chemical class 0.000 description 1
150000004696 coordination complex Chemical class 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
238000003869 coulometry Methods 0.000 description 1
229960003624 creatine Drugs 0.000 description 1
239000006046 creatine Substances 0.000 description 1
238000013500 data storage Methods 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
229960000648 digitoxin Drugs 0.000 description 1
WDJUZGPOPHTGOT-XUDUSOBPSA-N digitoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O WDJUZGPOPHTGOT-XUDUSOBPSA-N 0.000 description 1
229960005156 digoxin Drugs 0.000 description 1
LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000003487 electrochemical reaction Methods 0.000 description 1
238000005868 electrolysis reaction Methods 0.000 description 1
238000006056 electrooxidation reaction Methods 0.000 description 1
229920006334 epoxy coating Polymers 0.000 description 1
IXZISFNWUWKBOM-ARQDHWQXSA-N fructosamine Chemical compound NC[C@@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O IXZISFNWUWKBOM-ARQDHWQXSA-N 0.000 description 1
229960002518 gentamicin Drugs 0.000 description 1
108010054770 glucose dehydrogenase (pyrroloquinoline-quinone) Proteins 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000010931 gold Substances 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
238000007641 inkjet printing Methods 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
238000010030 laminating Methods 0.000 description 1
238000007648 laser printing Methods 0.000 description 1
239000003446 ligand Substances 0.000 description 1
239000004973 liquid crystal related substance Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
239000000203 mixture Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
229910052762 osmium Inorganic materials 0.000 description 1
SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
238000010422 painting Methods 0.000 description 1
229910052763 palladium Inorganic materials 0.000 description 1
150000002978 peroxides Chemical class 0.000 description 1
238000000206 photolithography Methods 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229910052697 platinum Inorganic materials 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
238000004313 potentiometry Methods 0.000 description 1
238000007639 printing Methods 0.000 description 1
230000008569 process Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
229940039716 prothrombin Drugs 0.000 description 1
238000006722 reduction reaction Methods 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
229910052707 ruthenium Inorganic materials 0.000 description 1
238000005070 sampling Methods 0.000 description 1
238000007650 screen-printing Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
239000002356 single layer Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
210000004243 sweat Anatomy 0.000 description 1
210000001138 tear Anatomy 0.000 description 1
238000012360 testing method Methods 0.000 description 1
229960000278 theophylline Drugs 0.000 description 1
229910052723 transition metal Inorganic materials 0.000 description 1
150000003624 transition metals Chemical class 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
238000001771 vacuum deposition Methods 0.000 description 1
229960003165 vancomycin Drugs 0.000 description 1
MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
238000007740 vapor deposition Methods 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 1
229960005080 warfarin Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3272—Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Pathology (AREA)
General Health & Medical Sciences (AREA)
Surgery (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medical Informatics (AREA)
Heart & Thoracic Surgery (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Optics & Photonics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
General Physics & Mathematics (AREA)
Biochemistry (AREA)
Analytical Chemistry (AREA)
Electrochemistry (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)

CA002647674A 2006-03-29 2007-03-28 Detecteurs d'analytes et leurs procedes d'utilisation Abandoned CA2647674A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11/277,931		2006-03-29
US11/277,931 US7887682B2 (en)	2006-03-29	2006-03-29	Analyte sensors and methods of use
PCT/US2007/007720 WO2007126920A1 (fr)	2006-03-29	2007-03-28	Détecteurs d'analytes et leurs procédés d'utilisation

Publications (1)

Publication Number	Publication Date
CA2647674A1 true CA2647674A1 (fr)	2007-11-08

Family

ID=38370487

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002647674A Abandoned CA2647674A1 (fr)	2006-03-29	2007-03-28	Detecteurs d'analytes et leurs procedes d'utilisation

Country Status (5)

Country	Link
US (3)	US7887682B2 (fr)
EP (1)	EP1999461A1 (fr)
CN (1)	CN101449155A (fr)
CA (1)	CA2647674A1 (fr)
WO (1)	WO2007126920A1 (fr)

Families Citing this family (159)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6391005B1 (en)	1998-03-30	2002-05-21	Agilent Technologies, Inc.	Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US8465425B2 (en)	1998-04-30	2013-06-18	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US8346337B2 (en)	1998-04-30	2013-01-01	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US8688188B2 (en)	1998-04-30	2014-04-01	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US8641644B2 (en)	2000-11-21	2014-02-04	Sanofi-Aventis Deutschland Gmbh	Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US7981056B2 (en)	2002-04-19	2011-07-19	Pelikan Technologies, Inc.	Methods and apparatus for lancet actuation
US9795747B2 (en)	2010-06-02	2017-10-24	Sanofi-Aventis Deutschland Gmbh	Methods and apparatus for lancet actuation
ATE485766T1 (de)	2001-06-12	2010-11-15	Pelikan Technologies Inc	Elektrisches betätigungselement für eine lanzette
US7041068B2 (en)	2001-06-12	2006-05-09	Pelikan Technologies, Inc.	Sampling module device and method
US9427532B2 (en)	2001-06-12	2016-08-30	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
US8337419B2 (en)	2002-04-19	2012-12-25	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
AU2002348683A1 (en)	2001-06-12	2002-12-23	Pelikan Technologies, Inc.	Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US9226699B2 (en)	2002-04-19	2016-01-05	Sanofi-Aventis Deutschland Gmbh	Body fluid sampling module with a continuous compression tissue interface surface
ES2336081T3 (es)	2001-06-12	2010-04-08	Pelikan Technologies Inc.	Dispositivo de puncion de auto-optimizacion con medios de adaptacion a variaciones temporales en las propiedades cutaneas.
US8579831B2 (en)	2002-04-19	2013-11-12	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US9314194B2 (en)	2002-04-19	2016-04-19	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
US7331931B2 (en)	2002-04-19	2008-02-19	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7901362B2 (en)	2002-04-19	2011-03-08	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7674232B2 (en)	2002-04-19	2010-03-09	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US8267870B2 (en)	2002-04-19	2012-09-18	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for body fluid sampling with hybrid actuation
US7491178B2 (en)	2002-04-19	2009-02-17	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7909778B2 (en)	2002-04-19	2011-03-22	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7175642B2 (en)	2002-04-19	2007-02-13	Pelikan Technologies, Inc.	Methods and apparatus for lancet actuation
US8221334B2 (en)	2002-04-19	2012-07-17	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US8360992B2 (en)	2002-04-19	2013-01-29	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US9795334B2 (en)	2002-04-19	2017-10-24	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for penetrating tissue
US7976476B2 (en)	2002-04-19	2011-07-12	Pelikan Technologies, Inc.	Device and method for variable speed lancet
US7297122B2 (en)	2002-04-19	2007-11-20	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7226461B2 (en)	2002-04-19	2007-06-05	Pelikan Technologies, Inc.	Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7547287B2 (en)	2002-04-19	2009-06-16	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7892183B2 (en)	2002-04-19	2011-02-22	Pelikan Technologies, Inc.	Method and apparatus for body fluid sampling and analyte sensing
US7232451B2 (en)	2002-04-19	2007-06-19	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US7229458B2 (en)	2002-04-19	2007-06-12	Pelikan Technologies, Inc.	Method and apparatus for penetrating tissue
US8372016B2 (en)	2002-04-19	2013-02-12	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for body fluid sampling and analyte sensing
US9248267B2 (en)	2002-04-19	2016-02-02	Sanofi-Aventis Deustchland Gmbh	Tissue penetration device
US8702624B2 (en)	2006-09-29	2014-04-22	Sanofi-Aventis Deutschland Gmbh	Analyte measurement device with a single shot actuator
US8784335B2 (en)	2002-04-19	2014-07-22	Sanofi-Aventis Deutschland Gmbh	Body fluid sampling device with a capacitive sensor
US8574895B2 (en)	2002-12-30	2013-11-05	Sanofi-Aventis Deutschland Gmbh	Method and apparatus using optical techniques to measure analyte levels
EP1628567B1 (fr)	2003-05-30	2010-08-04	Pelikan Technologies Inc.	Procede et appareil pour injection de fluide
EP1633235B1 (fr)	2003-06-06	2014-05-21	Sanofi-Aventis Deutschland GmbH	Appareil d'echantillonnage de fluides anatomiques et d'examen de l'analysat
WO2006001797A1 (fr)	2004-06-14	2006-01-05	Pelikan Technologies, Inc.	Element penetrant peu douloureux
US20190357827A1 (en)	2003-08-01	2019-11-28	Dexcom, Inc.	Analyte sensor
EP1671096A4 (fr)	2003-09-29	2009-09-16	Pelikan Technologies Inc	Procede et appareil permettant d'obtenir un dispositif de capture d'echantillons ameliore
US9351680B2 (en)	2003-10-14	2016-05-31	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for a variable user interface
US7822454B1 (en)	2005-01-03	2010-10-26	Pelikan Technologies, Inc.	Fluid sampling device with improved analyte detecting member configuration
EP1706026B1 (fr)	2003-12-31	2017-03-01	Sanofi-Aventis Deutschland GmbH	Procédé et appareil permettant d'améliorer le flux fluidique et le prélèvement d'échantillons
WO2006011062A2 (fr)	2004-05-20	2006-02-02	Albatros Technologies Gmbh & Co. Kg	Hydrogel imprimable pour biocapteurs
WO2005120365A1 (fr)	2004-06-03	2005-12-22	Pelikan Technologies, Inc.	Procede et appareil pour la fabrication d'un dispositif d'echantillonnage de liquides
US9775553B2 (en)	2004-06-03	2017-10-03	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for a fluid sampling device
US9259175B2 (en)	2006-10-23	2016-02-16	Abbott Diabetes Care, Inc.	Flexible patch for fluid delivery and monitoring body analytes
US9572534B2 (en)	2010-06-29	2017-02-21	Abbott Diabetes Care Inc.	Devices, systems and methods for on-skin or on-body mounting of medical devices
US8333714B2 (en)	2006-09-10	2012-12-18	Abbott Diabetes Care Inc.	Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9788771B2 (en)	2006-10-23	2017-10-17	Abbott Diabetes Care Inc.	Variable speed sensor insertion devices and methods of use
US20090105569A1 (en)	2006-04-28	2009-04-23	Abbott Diabetes Care, Inc.	Introducer Assembly and Methods of Use
US10226207B2 (en)	2004-12-29	2019-03-12	Abbott Diabetes Care Inc.	Sensor inserter having introducer
US9636450B2 (en)	2007-02-19	2017-05-02	Udo Hoss	Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
US7697967B2 (en)	2005-12-28	2010-04-13	Abbott Diabetes Care Inc.	Method and apparatus for providing analyte sensor insertion
US8652831B2 (en)	2004-12-30	2014-02-18	Sanofi-Aventis Deutschland Gmbh	Method and apparatus for analyte measurement test time
US11298058B2 (en)	2005-12-28	2022-04-12	Abbott Diabetes Care Inc.	Method and apparatus for providing analyte sensor insertion
US7885698B2 (en)	2006-02-28	2011-02-08	Abbott Diabetes Care Inc.	Method and system for providing continuous calibration of implantable analyte sensors
US7887682B2 (en) *	2006-03-29	2011-02-15	Abbott Diabetes Care Inc.	Analyte sensors and methods of use
US7630748B2 (en)	2006-10-25	2009-12-08	Abbott Diabetes Care Inc.	Method and system for providing analyte monitoring
US8219173B2 (en)	2008-09-30	2012-07-10	Abbott Diabetes Care Inc.	Optimizing analyte sensor calibration
US8224415B2 (en)	2009-01-29	2012-07-17	Abbott Diabetes Care Inc.	Method and device for providing offset model based calibration for analyte sensor
US9675290B2 (en)	2012-10-30	2017-06-13	Abbott Diabetes Care Inc.	Sensitivity calibration of in vivo sensors used to measure analyte concentration
AU2007308804A1 (en)	2006-10-26	2008-05-02	Abbott Diabetes Care, Inc.	Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US20080199894A1 (en)	2007-02-15	2008-08-21	Abbott Diabetes Care, Inc.	Device and method for automatic data acquisition and/or detection
GB0711780D0 (en) *	2007-06-18	2007-07-25	Oxford Biosensors Ltd	Electrochemical data rejection methodology
EP2171031B1 (fr)	2007-06-21	2018-12-05	Abbott Diabetes Care Inc.	Dispositifs et procédés de gestion de la santé
US8160900B2 (en)	2007-06-29	2012-04-17	Abbott Diabetes Care Inc.	Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
EP2211170A1 (fr) *	2007-10-31	2010-07-28	ARKRAY, Inc.	Instrument d'analyse, analyseur, procede de detection de penurie d'echantillons et methode d'analyse d'echantillons
WO2009105709A1 (fr)	2008-02-21	2009-08-27	Dexcom, Inc.	Systèmes et procédés pour traiter, transmettre et afficher des données de détecteur
WO2009126900A1 (fr)	2008-04-11	2009-10-15	Pelikan Technologies, Inc.	Procédé et appareil pour dispositif de détection d’analyte
US8591410B2 (en)	2008-05-30	2013-11-26	Abbott Diabetes Care Inc.	Method and apparatus for providing glycemic control
US8924159B2 (en)	2008-05-30	2014-12-30	Abbott Diabetes Care Inc.	Method and apparatus for providing glycemic control
KR100972108B1 (ko) *	2008-07-09	2010-07-26	주식회사 올메디쿠스	바이오센서
US8876755B2 (en)	2008-07-14	2014-11-04	Abbott Diabetes Care Inc.	Closed loop control system interface and methods
US8956308B2 (en)	2008-09-29	2015-02-17	Bayer Healthcare Llc	Integrated-testing system
US9326707B2 (en)	2008-11-10	2016-05-03	Abbott Diabetes Care Inc.	Alarm characterization for analyte monitoring devices and systems
US9375169B2 (en)	2009-01-30	2016-06-28	Sanofi-Aventis Deutschland Gmbh	Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US9402544B2 (en)	2009-02-03	2016-08-02	Abbott Diabetes Care Inc.	Analyte sensor and apparatus for insertion of the sensor
WO2010099507A1 (fr)	2009-02-26	2010-09-02	Abbott Diabetes Care Inc.	Capteurs d'analyte améliorés et procédés de fabrication et d'utilisation de ceux-ci
WO2010138856A1 (fr)	2009-05-29	2010-12-02	Abbott Diabetes Care Inc.	Systèmes d'antenne de dispositif médical comportant des configurations d'antenne externe
US8372351B2 (en)	2009-05-29	2013-02-12	Abbott Diabetes Care Inc.	Glucose monitoring system with wireless communications
WO2010141922A1 (fr)	2009-06-04	2010-12-09	Abbott Diabetes Care Inc.	Procédé et système de mise à jour d'un dispositif médical
US9237864B2 (en)	2009-07-02	2016-01-19	Dexcom, Inc.	Analyte sensors and methods of manufacturing same
EP3689237B1 (fr)	2009-07-23	2021-05-19	Abbott Diabetes Care, Inc.	Procédé de fabrication et système de mesure d'analytes continue
US8357276B2 (en) *	2009-08-31	2013-01-22	Abbott Diabetes Care Inc.	Small volume test strips with large sample fill ports, supported test strips, and methods of making and using same
WO2011026147A1 (fr)	2009-08-31	2011-03-03	Abbott Diabetes Care Inc.	Dispositif et procédés de traitement de signal d'analyte
JP5795584B2 (ja)	2009-08-31	2015-10-14	アボットダイアベティスケアインコーポレイテッドＡｂｂｏｔｔＤｉａｂｅｔｅｓＣａｒｅＩｎｃ．	医療用装置
US20110048972A1 (en) *	2009-08-31	2011-03-03	Lifescan Scotland Limited	Multi-analyte test strip with shared counter/reference electrode and inline electrode configuration
WO2011053881A1 (fr)	2009-10-30	2011-05-05	Abbott Diabetes Care Inc.	Méthode et appareil pour détecter de faux états hypoglycémiques
EP2504466B1 (fr)	2009-11-23	2019-11-20	Proxim Diagnostics Corporation	Activation électrochimique commandée d'électrodes à base de carbone
IL209760A (en) *	2009-12-11	2015-05-31	Lifescan Scotland Ltd	A system and method for measuring filling is satisfactory
US20110186428A1 (en) *	2010-01-29	2011-08-04	Roche Diagnostics Operations, Inc.	Electrode arrangements for biosensors
US9041730B2 (en)	2010-02-12	2015-05-26	Dexcom, Inc.	Receivers for analyzing and displaying sensor data
US8529742B2 (en) *	2010-02-24	2013-09-10	Matthew K. Musho	Electrochemical sensor with controlled variation of working electrode
ES2881798T3 (es)	2010-03-24	2021-11-30	Abbott Diabetes Care Inc	Insertadores de dispositivos médicos y procedimientos de inserción y uso de dispositivos médicos
AU2011239548A1 (en)	2010-04-16	2012-01-19	Abbott Diabetes Care Inc.	Analyte monitoring device and methods
US8965476B2 (en)	2010-04-16	2015-02-24	Sanofi-Aventis Deutschland Gmbh	Tissue penetration device
US8726266B2 (en)	2010-05-24	2014-05-13	Abbott Diabetes Care Inc.	Method and system for updating a medical device
US11064921B2 (en)	2010-06-29	2021-07-20	Abbott Diabetes Care Inc.	Devices, systems and methods for on-skin or on-body mounting of medical devices
US10092229B2 (en)	2010-06-29	2018-10-09	Abbott Diabetes Care Inc.	Calibration of analyte measurement system
US9760679B2 (en)	2011-02-11	2017-09-12	Abbott Diabetes Care Inc.	Data synchronization between two or more analyte detecting devices in a database
WO2012108939A1 (fr)	2011-02-11	2012-08-16	Abbott Diabetes Care Inc.	Rétroaction provenant d'un nuage ou de prestataires de soins de santé, fournie à un payeur ou à un patient par l'intermédiaire d'un appareil de mesure ou d'un téléphone mobile
WO2012108938A1 (fr)	2011-02-11	2012-08-16	Abbott Diabetes Care Inc.	Applications logicielles résidant sur des dispositifs portatifs de détermination d'analyte
CN103619255B (zh)	2011-02-28	2016-11-02	雅培糖尿病护理公司	与分析物监测装置关联的装置、系统和方法以及结合了它们的装置
US10136845B2 (en)	2011-02-28	2018-11-27	Abbott Diabetes Care Inc.	Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
DK2688474T3 (en) *	2011-03-25	2015-05-11	Sanofi Aventis Deutschland	Device and method for analysis of body fluid
EP3575796B1 (fr)	2011-04-15	2020-11-11	DexCom, Inc.	Étalonnage avancé de capteur d'échantillon à analyser et détection d'erreur avancée
US20130085349A1 (en)	2011-06-21	2013-04-04	Yofimeter, Llc	Analyte testing devices
US8333716B1 (en)	2011-06-21	2012-12-18	Yofimeter, Llc	Methods for using an analyte testing device
US20120330188A1 (en)	2011-06-21	2012-12-27	Gadlight, Inc.	Cocking and Advancing Mechanism for Analyte Testing Device
WO2013015822A1 (fr)	2011-07-25	2013-01-31	Mikhail Briman	Cartouche pour tests diagnostiques
US9069536B2 (en)	2011-10-31	2015-06-30	Abbott Diabetes Care Inc.	Electronic devices having integrated reset systems and methods thereof
US9622691B2 (en)	2011-10-31	2017-04-18	Abbott Diabetes Care Inc.	Model based variable risk false glucose threshold alarm prevention mechanism
AU2012352560B2 (en)	2011-12-11	2017-01-19	Abbott Diabetes Care Inc.	Analyte sensor devices, connections, and methods
US11460430B2 (en) *	2012-04-04	2022-10-04	University Of Cincinnati	Sweat simulation, collecting and sensing systems
GB2501870B (en)	2012-04-13	2018-07-18	Smartcare Tech Limited	Improvements in and relating to sample measurement
EP2901153A4 (fr)	2012-09-26	2016-04-27	Abbott Diabetes Care Inc	Procédé et appareil d'amélioration de correction de retard pendant une mesure in vivo de concentration de substance à analyser avec des données de variabilité et de plage de concentration de substance à analyser
US10433773B1 (en)	2013-03-15	2019-10-08	Abbott Diabetes Care Inc.	Noise rejection methods and apparatus for sparsely sampled analyte sensor data
US9474475B1 (en)	2013-03-15	2016-10-25	Abbott Diabetes Care Inc.	Multi-rate analyte sensor data collection with sample rate configurable signal processing
US10076285B2 (en)	2013-03-15	2018-09-18	Abbott Diabetes Care Inc.	Sensor fault detection using analyte sensor data pattern comparison
US10041901B2 (en) *	2013-03-15	2018-08-07	Roche Diabetes Care, Inc.	Electrode configuration for a biosensor
CN103412012B (zh) *	2013-03-28	2015-09-09	利多(香港)有限公司	生物传感器
EP4736749A2 (fr)	2013-04-30	2026-05-06	Abbott Diabetes Care Inc.	Systèmes, dispositifs et procédés d'activation de dispositif électrique éco-énergétique
US9435762B2 (en) *	2013-06-27	2016-09-06	Lifescan Scotland Limited	Fill error trap for an analyte measurement determined from a specified sampling time derived from a sensed physical characteristic of the sample containing the analyte
GB2519110B (en) *	2013-10-09	2018-04-18	Nokia Technologies Oy	An apparatus and associated methods for analyte detection
US9500616B2 (en) *	2013-12-23	2016-11-22	Cilag Gmbh International	Multi-orientation test strip
US10360368B2 (en)	2013-12-27	2019-07-23	Abbott Diabetes Care Inc.	Application interface and display control in an analyte monitoring environment
AU2014374361B9 (en)	2013-12-31	2019-07-04	Abbott Diabetes Care Inc.	Self-powered analyte sensor and devices using the same
US9897566B2 (en) *	2014-01-13	2018-02-20	Changsha Sinocare Inc.	Disposable test sensor
US20170185748A1 (en)	2014-03-30	2017-06-29	Abbott Diabetes Care Inc.	Method and Apparatus for Determining Meal Start and Peak Events in Analyte Monitoring Systems
US20170238851A1 (en) *	2014-08-26	2017-08-24	Echo Therapeutics, Inc.	Differential Biosensor System
JP6526193B2 (ja) *	2014-11-03	2019-06-05	エフホフマン−ラロッシュアクチェンゲゼルシャフト	電気化学的テストエレメントのための電極配置およびその使用方法
US10161897B2 (en) *	2015-01-09	2018-12-25	Xerox Corporation	Sensors incorporating palladium electrodes
CA2984939A1 (fr)	2015-05-14	2016-11-17	Abbott Diabetes Care Inc.	Instruments d'introduction de dispositifs medicaux compacts et systemes et procedes associes
US11553883B2 (en)	2015-07-10	2023-01-17	Abbott Diabetes Care Inc.	System, device and method of dynamic glucose profile response to physiological parameters
US10888272B2 (en)	2015-07-10	2021-01-12	Abbott Diabetes Care Inc.	Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation
CN106226379A (zh) *	2016-07-10	2016-12-14	浙江亿联健医疗器械有限公司	一种消除进样过程影响的生物传感器及测试方法
TWI609182B (zh) *	2016-11-04	2017-12-21	五鼎生物技術股份有限公司	葡萄糖量測裝置與設備
US11071478B2 (en)	2017-01-23	2021-07-27	Abbott Diabetes Care Inc.	Systems, devices and methods for analyte sensor insertion
US11331022B2 (en)	2017-10-24	2022-05-17	Dexcom, Inc.	Pre-connected analyte sensors
US11382540B2 (en)	2017-10-24	2022-07-12	Dexcom, Inc.	Pre-connected analyte sensors
US10816453B2 (en) *	2017-11-03	2020-10-27	Sharp Life Science (Eu) Limited	Co-planar micro-impedance cytometry device
ES2927989T3 (es)	2017-11-21	2022-11-14	Mx3 Diagnostics Inc	Sistema y procedimiento de análisis de saliva
WO2020056167A1 (fr) *	2018-09-12	2020-03-19	Ohio State Innovation Foundation	Actionneurs chimiques
MX2021007294A (es)	2018-12-21	2021-07-15	Abbott Diabetes Care Inc	Sistemas, dispositivos y metodos para la insercion de sensores de analito.
US11701036B2 (en)	2019-07-10	2023-07-18	MX3 Diagnostics, Inc.	Saliva test strip and method
CN112294320B (zh) *	2019-08-02	2024-06-11	华广生技股份有限公司	植入式微型生物传感器
US11737689B2 (en)	2019-08-02	2023-08-29	Bionime Corporation	Physiological signal monitoring device
EP4090243A4 (fr)	2020-01-15	2023-12-20	MX3 Diagnostics, Inc.	Évaluation d'une concentration d'un biomarqueur dans un fluide
US11703436B2 (en) *	2020-01-30	2023-07-18	MX3 Diagnostics, Inc.	Biological fluid sample assessment
EP4176447A1 (fr)	2020-07-01	2023-05-10	Abbott Diabetes Care Inc.	Systèmes, dispositifs et procédés de collecte d'informations de repas, évaluation de repas et corrélation de données d'analytes
EP4178439A1 (fr) *	2020-07-10	2023-05-17	Abbott Diabetes Care Inc.	Systèmes et procédés de réduction de signal d'arrière-plan dans des biocapteurs
USD957438S1 (en)	2020-07-29	2022-07-12	Abbott Diabetes Care Inc.	Display screen or portion thereof with graphical user interface
EP4203819B1 (fr)	2020-08-31	2024-07-31	Abbott Diabetes Care Inc.	Systèmes, dispositifs et procédés d'insertion de capteur d'analyte
ES3000715T3 (en)	2020-09-15	2025-03-03	Abbott Diabetes Care Inc	Device for analyte monitoring
JP2024527596A (ja)	2021-07-16	2024-07-25	アボットダイアベティスケアインコーポレイテッド	検体監視のためのシステム、装置、及び方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5141868A (en) *	1984-06-13	1992-08-25	Internationale Octrooi Maatschappij "Octropa" Bv	Device for use in chemical test procedures
AUPN363995A0 (en)	1995-06-19	1995-07-13	Memtec Limited	Electrochemical cell
US5989409A (en) *	1995-09-11	1999-11-23	Cygnus, Inc.	Method for glucose sensing
AUPO585797A0 (en)	1997-03-25	1997-04-24	Memtec America Corporation	Improved electrochemical cell
US6071391A (en) *	1997-09-12	2000-06-06	Nok Corporation	Enzyme electrode structure
US6338790B1 (en) *	1998-10-08	2002-01-15	Therasense, Inc.	Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
DE19916921A1 (de) *	1999-04-14	2000-10-19	Fraunhofer Ges Forschung	Elektrisches Sensorarray
US6841052B2 (en) *	1999-08-02	2005-01-11	Bayer Corporation	Electrochemical-sensor design
US6616819B1 (en) *	1999-11-04	2003-09-09	Therasense, Inc.	Small volume in vitro analyte sensor and methods
US6447657B1 (en)	2000-12-04	2002-09-10	Roche Diagnostics Corporation	Biosensor
US6572745B2 (en) *	2001-03-23	2003-06-03	Virotek, L.L.C.	Electrochemical sensor and method thereof
US6743635B2 (en) *	2002-04-25	2004-06-01	Home Diagnostics, Inc.	System and methods for blood glucose sensing
US6801041B2 (en) *	2002-05-14	2004-10-05	Abbott Laboratories	Sensor having electrode for determining the rate of flow of a fluid
EP1642126A1 (fr)	2003-06-20	2006-04-05	Roche Diagnostics GmbH	Systeme et procede de codage d'informations sur une bandelette d'essai de type biocapteur
CA2529300C (fr) *	2003-06-20	2011-10-18	F.Hoffmann-La Roche Ag	Dispositifs et procedes en relation avec des biocapteurs electrochimiques
US7452457B2 (en) *	2003-06-20	2008-11-18	Roche Diagnostics Operations, Inc.	System and method for analyte measurement using dose sufficiency electrodes
US7718439B2 (en) *	2003-06-20	2010-05-18	Roche Diagnostics Operations, Inc.	System and method for coding information on a biosensor test strip
US8206565B2 (en) *	2003-06-20	2012-06-26	Roche Diagnostics Operation, Inc.	System and method for coding information on a biosensor test strip
US7418285B2 (en) *	2004-12-29	2008-08-26	Abbott Laboratories	Analyte test sensor and method of manufacturing the same
US7887682B2 (en) *	2006-03-29	2011-02-15	Abbott Diabetes Care Inc.	Analyte sensors and methods of use

2006
- 2006-03-29 US US11/277,931 patent/US7887682B2/en not_active Expired - Fee Related
2007
- 2007-03-28 EP EP07754268A patent/EP1999461A1/fr not_active Withdrawn
- 2007-03-28 CA CA002647674A patent/CA2647674A1/fr not_active Abandoned
- 2007-03-28 WO PCT/US2007/007720 patent/WO2007126920A1/fr not_active Ceased
- 2007-03-28 CN CN200780015566.XA patent/CN101449155A/zh active Pending
2009
- 2009-05-08 US US12/463,206 patent/US8083927B2/en not_active Expired - Fee Related
2011
- 2011-12-06 US US13/312,190 patent/US8419927B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US8083927B2 (en)	2011-12-27
US7887682B2 (en)	2011-02-15
US20120078073A1 (en)	2012-03-29
CN101449155A (zh)	2009-06-03
US20090240166A1 (en)	2009-09-24
EP1999461A1 (fr)	2008-12-10
US8419927B2 (en)	2013-04-16
WO2007126920A1 (fr)	2007-11-08
US20070227911A1 (en)	2007-10-04

Legal Events

Date	Code	Title	Description
2012-02-28	EEER	Examination request
2014-05-25	FZDE	Discontinued	Effective date: 20140328

Publication	Publication Date	Title
US8083927B2 (en)	2011-12-27	Analyte sensors and methods of use
US9465005B2 (en)	2016-10-11	Analyte sensors and methods of use
US7846311B2 (en)	2010-12-07	In vitro analyte sensor and methods of use
CA2659621C (fr)	2016-10-04	Procedes de fabrication de detecteurs d'analyte calibres